Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials GroupMalcolm J. Moore, Wendy R. Parulekar, Mieke Ptasynski et al.|Journal of Clinical Oncology|2007Cited by 3.9k
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract CancersRachna T. Shroff, Mitesh J. Borad, Milind Javle et al.|JAMA Oncology|2019Cited by 472
Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experienceNora A. Janjan, John M. Skibber, Vincent Khoo et al.|International Journal of Radiation Oncology*Biology*Physics|1999Cited by 468
<sup>Non-V600</sup><i>BRAF</i> Mutations Define a Clinically Distinct Molecular Subtype of Metastatic Colorectal CancerJeremy Jones, Axel Grothey, Lindsay A. Renfro et al.|Journal of Clinical Oncology|2017Cited by 357
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Elshad Hasanov et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255